China's First Major Pacemaker Study Shows Efficacy Of Latest Model
This article was originally published in PharmAsia News
Executive Summary
China's first major pacemaker study has demonstrated efficacy for a new model that works automatically on its own
China's first major pacemaker study has demonstrated efficacy for a new model that works automatically on its own. U.S.-based Medtronic's EnPulse pacemaker is being tested in China to see if, as intended, it expands patient life quality and extends the battery life of the device. The EnPulse study is the first multicenter, randomized pacemaker study conducted in China. (Click here for more) "Results From China's First Large Pacemaker Study Presented At U.S. Conference" - Xinhua (China) (5/17/10) |